Dr. Anastasia GeorgiadiHead of Junior Group Endocrine Pharmacology, Institute of Diabetes and Cancer (IDC)
Group Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich
Project Team Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich
Postdoctoral fellow, Department of Adipose Tissue Biology, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich
Postdoctoral fellow, Department of Cell and Molecular Biology, Karolinska Institute, Sweden
Honors and Awards
Since 2018 - EFSD/Lilly Award
2012 - Rubicon Postdoctoral Mobility Fellowship, The Netherlands Organisation for Scientific Research (NWO)
Highlight PublicationsMore on PubMed
Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue.
Mol Aspects Med
The role of brown and beige adipose tissue in glycaemic control.
Proc Natl Acad Sci
Horm Mol Biol Clin Investig
Endocrine and autocrine/paracrine modulators of brown adipose tissue mass and activity as novel therapeutic strategies against obesity and type 2 diabetes.
FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice.